In recent years, the healthcare industry in the United States has seen more use of artificial intelligence (AI) to improve patient care and make operations more efficient. One growing use is AI-driven autonomous telehealth follow-up consultations. These are often used for routine check-ins after a patient’s visit. These automated systems aim to increase clinical capacity and reduce costs, but they also raise important questions about how patients feel about not having human interaction during these consultations.
This article looks at how medical practice managers, owners, and IT managers can understand patient views and the psychological effects of using AI-powered telehealth services. It also talks about how AI automation fits into clinical work and suggests practical ways to safely use these technologies in U.S. healthcare.
Telehealth has grown a lot recently across the United States because people want healthcare that is easy to access and fast. AI assistants that work on their own, such as voice-based phone agents, have been made to do routine follow-up calls that used to take staff time. For example, in the UK, there is an AI clinical assistant called Dora R1. It shows how AI can safely and well handle post-surgery follow-up calls without humans.
Studies show that Dora R1 has a sensitivity of 94% and specificity of 86% in finding patients who need more care after cataract surgery. The AI finished 96.5% of calls without help from humans. This saved staff £35.18 per patient compared to normal care. Even though this example is from outside the U.S., it shows where healthcare technology is going. This is especially true for many routine follow-ups that can make staff very busy in clinics.
In the United States, healthcare leaders are looking into these systems to help with more patient demand, shorter wait times, lower costs for follow-ups, and letting clinicians focus on harder cases. AI automation fits well with value-based care, which focuses on efficiency and patient satisfaction.
Still, even with good results in operation, how patients feel about less human contact is very important for acceptance and success.
AI-driven telehealth follow-ups have practical benefits, but it is important to pay attention to patients’ feelings and mental responses. Research about how patients react to AI in healthcare—especially in diagnosis and follow-ups—shows a variety of thoughts, feelings, and worries that affect how patients accept it.
Many patients like AI-driven healthcare because it is convenient, less expensive, and fast. They like that AI assistants are available all day and night, so they can get information anytime, not just during office hours. AI also helps doctors by giving confirmed advice for follow-ups.
For simple, low-risk follow-ups like calls after cataract surgery, patients often accept automated AI systems. They understand that automation can cut down wait times and stop unnecessary visits. These benefits can make their healthcare experience better.
Despite these good points, many patients feel a sense of loss because there is no human in AI consultations. Some patients say talking to machines feels less personal and less caring. Human interaction brings emotional support and understanding that AI cannot give yet.
These concerns are stronger in difficult or sensitive cases, where patients want personal care and reassurance from a human healthcare provider. Some patients doubt how reliable AI decisions are because they think AI can make mistakes and it is not clear how AI works. These feelings can reduce trust and may make patients less likely to follow care advice.
Patients also worry about privacy. They are concerned about how their personal health data is handled and stored by AI systems. The unclear nature of AI decisions makes some patients fear their data will be misused or errors will go unnoticed.
Medical administrators and IT managers need to deal with these worries by being clear about data use, having strong data security, and making AI operations transparent. Giving patients information on how their data is used and ensuring doctors oversee AI processes can ease these fears.
Research by Hajiheydari, Delgosha, and Saheb in the journal Social Science & Medicine uses Behavioural Reasoning Theory to study how patients think about AI diagnostics. The study says patients think about both the good and bad sides of AI. Whether they accept AI depends on their situation and their own thoughts.
The results suggest that AI should be designed with patients in mind. This includes having human oversight for complex decisions and adding signs of empathy in the AI interface if possible. These things can help increase patient trust and make them more willing to use AI for follow-ups.
For medical practice managers and owners in the U.S., understanding how patients view AI-driven telehealth is important for success. Because the U.S. has many different kinds of people, things like culture, health knowledge, and past experience with technology can change how patients feel about AI.
The Dora R1 study shows that AI systems can work under doctor supervision to be safe and good quality. Doctors watch over cases flagged by AI and get involved when human judgment is needed, especially in hard or unclear cases.
Using these combined models may help patients trust AI more because they know human professionals are involved with important decisions. It also helps follow rules and avoids legal problems.
Good communication can help patients feel better about AI. It is important to explain that AI supports but does not replace doctors. Pointing out things like faster follow-ups, shorter phone wait times, and ongoing patient monitoring can make patients more confident about AI services.
Materials like patient guides, FAQ sheets, and staff training can support these messages and answer patient questions about data privacy, AI accuracy, and what to do if they think AI did not handle their case well.
The way AI telehealth tools are designed also matters. The software and scripts should try to lower feelings of being less cared for. This can be done by using natural language, a caring tone, and giving clear choices for patients to talk to a human if they want.
Testing programs and regularly gathering patient feedback are necessary to improve these AI systems based on real use.
AI automation in clinical workflows is rising in many parts of American healthcare. Automating phone calls for post-visit follow-ups shows how AI can change routine administrative and care tasks.
Manual follow-up calls take a lot of time from front desk staff and clinical workers. Autonomous AI agents can handle many standard calls and sort patients effectively. This lets staff focus on urgent clinical tasks, reduces burnout, and makes better use of resources.
For example, Simbo AI offers front-office phone automation and AI answering services made for healthcare. Using such AI can improve operations without hurting patient relationships or clinical safety.
Systems like Dora R1 check important clinical symptoms during follow-up calls. They decide if patients need more help or can be safely discharged. These systems increase clinical capacity by focusing on cases that really need care, lowering unnecessary visits, and improving access for urgent patients.
By adding AI automation to workflows, managers can balance patient load and make clinicians more productive without lowering quality or safety.
Safety is the most important thing when automating clinical work. AI follow-up systems must be used with doctor oversight to catch any unexpected problems quickly. The Dora R1 study showed that no patients sent home by AI needed a second review after callbacks, supporting safety when doctors supervise.
In U.S. medical practices, following HIPAA rules, FDA digital health guidelines, and hospital policies will guide AI workflow use. IT managers have an important job setting up these systems for security and working well with other systems.
AI automation in telehealth follow-ups can lower costs for healthcare by cutting staff hours spent on routine calls. The mentioned study showed staff cost savings of about £35.18 per patient. This adds up to big savings overall.
For managers who handle budgets and resources, AI can help lower operating costs while keeping or improving care quality.
Even though AI has many benefits, adding it to current workflows takes planning and teamwork. Practice managers and IT staff need to make sure staff are trained well, have clear steps for urgent cases, and that AI works smoothly with electronic health records (EHR) systems.
Patient feedback systems must be made so problems are found early and used to improve AI steadily.
AI-driven autonomous telehealth follow-ups offer a new way for American healthcare practices to deliver care. However, it is important to notice and respond to patient worries about losing human contact for AI to be successful.
Healthcare groups that want to use AI in telehealth need to balance making things faster with keeping care personal, trustworthy, and caring. By combining technology with careful doctor oversight and attention to patient needs, AI can become a useful tool for routine follow-up care in the United States.
Medical practice managers, owners, and IT staff have an important role in checking AI not only for how well it works but also for how it affects patient experience. Using research and making AI designs focused on patients will help AI fit well into future telehealth services nationwide.
Dora R1 is designed to conduct autonomous telemedicine follow-up assessments for cataract surgery patients, identifying and prioritizing those who need further clinical input, thereby expanding clinical capacity and improving patient triage post-surgery.
The accuracy was assessed by comparing Dora R1’s decisions on clinical symptoms and need for further review against those of supervising ophthalmologists in a sample of 202 patients following cataract surgery.
Dora R1 demonstrated an overall sensitivity of 94% and specificity of 86%, showing strong alignment with clinical decisions made by ophthalmologists.
Dora R1 showed moderate to strong agreement with clinicians, with kappa coefficients ranging from 0.758 to 0.970 across assessed clinical parameters, indicating high reliability in clinical decision-making.
Safety was affirmed as no patients incorrectly discharged by Dora R1 required additional follow-up after a callback. Unexpected management changes were minimal and coincided with clinician recommendations, indicating safe clinical use.
Feasibility was shown with 96.5% of calls completed autonomously by Dora R1, while usability and acceptability were generally positive, although some patients expressed concerns about the absence of human interaction in complex cases.
Patients generally accepted routine AI follow-ups but worried about the absence of a human component in managing complications, indicating sensitivity to the emotional and clinical nuances of AI communication.
Dora R1 reduced staff costs by approximately £35.18 per patient, highlighting important economic advantages in resource allocation for routine post-surgical follow-ups.
The study recommends further real-world implementation studies involving larger and more diverse patient populations across multiple Trusts to validate safety, effectiveness, and generalizability.
Dora R1 evaluated the clinical significance of five key symptoms commonly monitored post-cataract surgery to decide if patients required further clinical review or could be safely discharged.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
